CK Life Sciences (Holdings) (HKG:0775) reported a loss attributable to shareholders of HK$150.8 million for the six months ended June 30, compared with a profit of HK$1.0 million in the same period last year, according to a Tuesday Hong Kong bourse filing.
Basic loss per share was HK$0.0157, compared with earnings per share of HK$0.0001 a year earlier.
Revenue declined slightly to HK$2.61 billion from HK$2.64 billion in the prior year period.
The board did not declare an interim dividend for the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.